Genetic Factors in Alzheimer's Disease
NEJM 352: 862-863, 884, Bird, T., 2005
Giant Tumefactive Perivascular Spaces
AJNR 26:298-305, Salzman, K.L., et al, 2005
Memory Dysfunction
NEJM 352:692-699, Budson, A.E. & Price, B.H., 2005
Risk of Ischaemic Stroke in People With Migraine: Systemic Review and Meta-analysis of Observational Studies
BMJ 330:63-65, 54, Etminan,M.,et al, 2005
Association Between Hormone Replacement Therapy and Subsequent Stroke: A Meta-analysis
BMJ 330:342-345, Bath, P.M.W. & Gray, L.J., 2005
Clinicopath Conf, Acute Myelogenous Leukemia Presenting as Meningitis
NEJM 352:274-283, Case 2-2005, 2005
Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 352:1343-1356, Koller,H.,et al, 2005
Safety and Efficacy of Endovascular Treatment of Carotid Artery Stenosis Compared with Carotid Endarterectomy
Stroke 36:905-911, Coward,L.J., et al, 2005
Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients with Nonrheumatic ATrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 36:914-915, Saxena,R. &Koudstaal,P.J., 2005
Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005
Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
NEJM 352:1305-1316, 1368, Chimowitz,M.I.,et al, 2005
Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005
Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005
Ximelagatran--Promises and Concerns
JAMA 293:736-739, Gurewich,V., 2005
Pure Midbrain Infarction
Neurol 64:1227-1232, Kim,J.S. & Kim,J., 2005
Management of Acute Cerebellar Stroke
Arch Neurol 62:537-544, Jensen,M.B. &St. Louis,E.K., 2005
Simultaneous Carotid Endarterectomy and Coronary Artery Bypass Surgery in Canada
Neurol 64:1435-1437,1332, Hill,M.D.,et al, 2005
Anti-a4 Integrin Therapy for Multiple Sclerosis
Neurol 64:1336-1342, Rice,G.P.A.,et al, 2005
Autonomic Peripheral Neuropathy
Lancet 365:1259-1270, Freeman,R., 2005
Rehabilitation After Stroke
NEJM 352:1677-1684, Dobkin,B.H., 2005
Magnetic Susceptibility-Weighted MR Phase Imaging of the Human Brain
AJNR 26:736-742, Rauscher,A.,et al, 2005
Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005
Ruptured Cerebral Aneurysms
NEJM 352:121-124, Ellegala,D.B. & Day,A.L., 2005
Attention Deficit-Hyperactivity Disorder
NEJM 352:165-173, Rappley,M.D., 2005
Neurologic and Developmental Disability at Six Years of Age After Extremely Preterm Birth
NEJM 352:9-19, 71, Marlow,N.,et al, 2005
Factors Influencing PCR Detection of Viruses in Cerebrospinal Fluid of Patients with Suspected CNS Infections
JNNP 76:82-87, Davies,N.W.S.,et al, 2005
Dipyridamole for Preventing Recurrent Ischemic Stroke and Other Vascular Events
Stroke 36:162-168, Leonardi-Bee,J.,et al, 2005
Management of Depression After Stroke
Stroke 36:1092-1097, Hackett,M.L.,et al, 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005
Physical Methods for Preventing Deep Vein Thrombosis in Stroke
Stroke 36:1102-1103, Grandi,F.C.,et al, 2005
Does This Patient Have Myasthenia Gravis?
JAMA 293:1906-1914, Scherer,K.,et al, 2005
Persistent Low Back Pain
NEJM 352:1891-1898, Carragee,E.J., 2005
Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005
The Neurologist and Patient Safety
Neurologist 11:140-149, Glick,T.H., 2005
Internuclear Ophthalmoplegia
Arch Neurol 62:714-717, Keane,J.R., 2005
Proton MR Spectroscopy in Wilson Disease: Analysis of 36 Cases
AJNR 26:1066-1071, Lucato,L.T.,et al, 2005
Position Statement Regarding the Use of Embryonic and Adult Human Stem Cells in Biomedical Research
Neurol 64:1679-1680,1675, American academy of Neurology and American Neurological Association, 2005
Apoplexy in Pituitary Macroadenoma: Eight Patients Presenting in 12 Months
Medicine 84:188-196, Imboden,E.,e tal, 2005
Diagnostic Criteria for Schwannomatosis
Neurol 64:1838-1845, MacCollin,M.,et al, 2005
Frontotemporal Lobar Degeneration
Arch Neurol 62:925-930, Johnson,J.K.,et al, 2005
Recommended Standard of Cerebrospial Fluid Analysis in the Diagnosis of Multiple Sclerosis, A Consensus Statement
Arch Neurol 62:865-870, Freedman,M.S.,et al, 2005
Isolated Monoparesis Following Stroke
JNNP 76:805-807, Paciaroni,M.,et al, 2005
Bells Palsy
BMJ 330:1374, Piercy, J, 2005
Vertigo
BMJ 330:523, Kanagalingam,J.,et al, 2005
Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005
Searching for a Relationship Between Manganese and Welding and Parkinsons Disease
Neurol 64:2021-2028, 2001, Jankovic,J., 2005
Practice Parameter:Therapies for Essential Tremor
Neurol 64:2008-2020, Zesiewicz,T.A.,et al, 2005
A Randomized Controlled Trial of Surgery vs Steroid Injection for Carpal Tunnel Syndrome
Neurol 64:2074-2078,2006, Hui,A.C.F.,et al, 2005
A Systematic Review of the Risk Factors for Cervical Artery Dissection
Stroke 36:1575-1580, Rubinstein,S.M.,et al, 2005
Recommendations for Comprehensive Stroke Centers, A Consensus Statement from the Brain Attach Coalition
Stroke 36:1597-1618, Alberts,M.J.,et al, 2005